David J Gajda Mda Professional Paradise, CA - 95969

David J Gajda Mda Professional is categorized under Medical Research in Paradise, CA and active since 2012.

David J Gajda Mda Professional was established in 2012, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 541720 by the NAICS.

If you are seeking more information, feel free to contact David J Gajda at the company’s single location by writing to 6283 Clark Road # 10, Paradise, California CA 95969 or by phoning (530) 877-2020. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: David J Gajda Mda Professional
Contact Person: David J Gajda
Address: 6283 Clark Road # 10, Paradise, California 95969
Phone Number: (530) 877-2020
Website Address: eyelife.net
Annual Revenue (USD): $500.000 to $999.999
Founded: 2012
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Medical Research
SIC Code: 8733
NAICS Code: 541720
Share This Business:

David J Gajda Mda Professional was started in 2012 to provide professional Medical Research under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact David J Gajda for inquiries that concern David J Gajda Mda Professional by calling the company number (530) 877-2020, as your correspondence is most welcome. Additionally, the physical location of the single location of David J Gajda Mda Professional can be found at the coordinates 39.767555,-121.600601 as well as the street address 6283 Clark Road # 10 in Paradise, California 95969.

For its online presence, you may visit David J Gajda Mda Professional’s website at eyelife.net and engage with its social media outlets through on Twitter and on Facebook.